These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32101116)

  • 1. Lignans and Neolignans Anti-tuberculosis Identified by QSAR and Molecular Modeling.
    S Maia M; de Sousa NF; Rodrigues GCS; Monteiro AFM; Scotti MT; Scotti L
    Comb Chem High Throughput Screen; 2020; 23(6):504-516. PubMed ID: 32101116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neolignans and phenylpropanoids from the roots of Piper taiwanense and their antiplatelet and antitubercular activities.
    Chen S; Huang HY; Cheng MJ; Wu CC; Ishikawa T; Peng CF; Chang HS; Wang CJ; Wong SL; Chen IS
    Phytochemistry; 2013 Sep; 93():203-9. PubMed ID: 23582215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophyllin-type bicyclo[3.2.1]octanoid neolignans from the leaves of Pleurothyrium cinereum.
    Coy ED; Cuca LE; Sefkow M
    J Nat Prod; 2009 Jul; 72(7):1245-8. PubMed ID: 19548690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tuberculosis neolignans from Piper regnellii.
    Scodro RB; Pires CT; Carrara VS; Lemos CO; Cardozo-Filho L; Souza VA; Corrêa AG; Siqueira VL; Lonardoni MV; Cardoso RF; Cortez DA
    Phytomedicine; 2013 May; 20(7):600-4. PubMed ID: 23474218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D
    Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines.
    Saxena AK; Alam M
    Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell wall permeability assisted virtual screening to identify potential direct InhA inhibitors of Mycobacterium tuberculosis and their biological evaluation.
    Kumar V; Jhamb SS; Sobhia ME
    J Biomol Struct Dyn; 2018 Sep; 36(12):3274-3290. PubMed ID: 28974157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis.
    Matviiuk T; Mori G; Lherbet C; Rodriguez F; Pasca MR; Gorichko M; Guidetti B; Voitenko Z; Baltas M
    Eur J Med Chem; 2014 Jan; 71():46-52. PubMed ID: 24269516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold.
    Pajk S; Živec M; Šink R; Sosič I; Neu M; Chung CW; Martínez-Hoyos M; Pérez-Herrán E; Álvarez-Gómez D; Álvarez-Ruíz E; Mendoza-Losana A; Castro-Pichel J; Barros D; Ballell-Pages L; Young RJ; Convery MA; Encinas L; Gobec S
    Eur J Med Chem; 2016 Apr; 112():252-257. PubMed ID: 26900657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First triclosan-based macrocyclic inhibitors of InhA enzyme.
    Rodriguez F; Saffon N; Sammartino JC; Degiacomi G; Pasca MR; Lherbet C
    Bioorg Chem; 2020 Jan; 95():103498. PubMed ID: 31855823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetate Kinase (AcK) is Essential for Microbial Growth and Betel-derived Compounds Potentially Target AcK, PhoP and MDR Proteins in M. tuberculosis, V. cholerae and Pathogenic E. coli: An in silico and in vitro Study.
    Tiwari S; Barh D; Imchen M; Rao E; Kumavath RK; Seenivasan SP; Jaiswal AK; Jamal SB; Kumar V; Ghosh P; Azevedo V
    Curr Top Med Chem; 2018; 18(31):2731-2740. PubMed ID: 30663567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR based therapeutic management of M. tuberculosis.
    Ahamad S; Rahman S; Khan FI; Dwivedi N; Ali S; Kim J; Imtaiyaz Hassan M
    Arch Pharm Res; 2017 Jun; 40(6):676-694. PubMed ID: 28456911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.
    Perryman AL; Yu W; Wang X; Ekins S; Forli S; Li SG; Freundlich JS; Tonge PJ; Olson AJ
    J Chem Inf Model; 2015 Mar; 55(3):645-59. PubMed ID: 25636146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR Selectivity Analysis of 1-Adamantyl-3-Heteroaryl Urea Analogs as Potent Inhibitors of Mycobacterium tuberculosis.
    Wadhwa P; Bagchi S; Sharma A
    Curr Comput Aided Drug Des; 2015; 11(2):164-83. PubMed ID: 26234390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR Studies, Synthesis and Antibacterial Assessment of New Inhibitors Against Multidrug-Resistant Mycobacterium tuberculosis.
    Kovalishyn V; Brovarets V; Blagodatnyi V; Kopernyk I; Hodyna D; Chumachenko S; Shablykin O; Kozachenko O; Vovk M; Barus M; Bratenko M; Metelytsia L
    Curr Drug Discov Technol; 2017; 14(1):25-38. PubMed ID: 27829331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Resveratrol and Lignans in the Management of Tuberculosis.
    Jubilee R; Komala M; Patel S
    Cell Biochem Biophys; 2024 Sep; 82(3):1809-1823. PubMed ID: 38914838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.